UBS


Good Q3 figures, earnings much better than expected

30/10/24 -"• Revenues were up by 5% to $12.3bn for the Q3 24 compared to Q3 23 • Total operating expenses declined by 12% to $10.3bn for the Q3 24 versus Q3 23. • Net result attributable to shareholders ..."

Pages
51
Language
English
Published on
30/10/24
You may also be interested by these reports :
01/07/25
As expected, BBVA announced its decision to maintain its offer on SAB, potentially responding to press articles mentioning confirmed interest in TSB. ...

18/06/25
Pbb has decided to completely discontinue pbb’s US business and to sell, securitise or respectively run-down the US portfolio. Pbb has said that, in ...

18/06/25
We have updated the share count following the successive buybacks performed by the group over the past months which have notably resulted in the full ...

11/06/25
As shown in the chart below, LBG’s (REDUCE; UK) stock has strongly overperformed the market over the past year, with a marked acceleration since the ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO